ORPH (ORPH) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 72 254 sessions, March 30, 2021 to March 30, 2022
- Largest daily move
- +301.5% close of June 10, 2021
- 1-year change
- -90.6% closing prices, March 30, 2021 to March 30, 2022
Company Description
ORPH (OTC: ORPH) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $37.3M.
ORPH has declined 90.6% over the past year. The last closing price was $0.8700.
This page collects what Stock Titan holds for ORPH, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
ORPH (ORPH) closed at $0.8700 on March 30, 2022. Over the past 12 months, the price has lost 90.6%.
ORPH Metrics & Rankings
Price returns through March 30, 2022. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
ORPH has 7 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 5 with negative movement. Key topics include fda approval, clinical trial. View all ORPH news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ORPH Company Profile & Sector Positioning
ORPH (ORPH) operates in the Biotechnology industry within the broader Healthcare sector.
Investors comparing ORPH often look at related companies in the same sector, including LAVA Therapeutics N.V. (LVTX), Klotho Neurosciences, Inc. (KLTO), Xilio Therapeutics, Inc. (XLO), Mersana Therapeutics, Inc. (MRSN), and LakeShore Biopharma Co., Ltd (LSB). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ORPH's relative position within its industry.